Revance therapeutics, inc. is being sued for securities law violations and affected investors are urged to contact the schall law firm

Los angeles, ca / access newswire / january 17, 2025 / the schall law firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against revance therapeutics, inc. ("revance" or "the company") (nasdaq:rvnc) for violations of 10(b) and 20(a) of the securities exchange act of 1934 and rule 10b-5 promulgated thereunder by the u.s. securities and exchange commission. investors who purchased the company's securities between february 29, 2024 and december 6, 2024, inclusive (the "class period"), are encouraged to contact the firm before march 4, 2025.
RVNC Ratings Summary
RVNC Quant Ranking